ALTA-002, a Toll-like receptor agonist antibody conjugate with promising antitumor activity in vivo Nov. 24, 2021
KAND-145 + cisplatin reduces tumor size in disease model of chemotherapy-resistant ovarian cancer Nov. 23, 2021
Erythrocyte miR-210 as target for prevention of endothelial dysfunction in type 2 diabetes Nov. 23, 2021
RSS